Alan Thomas, M.D.
NPI 1528066313 · Sleep Medicine (Internal Medicine) Physician · Birmingham, AL
Enrolled with Medicare as Practitioner - Sleep Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1528066313
- Entity type
- Individual
- Primary specialty
- Sleep Medicine (Internal Medicine) PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- K0388 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,485 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Subsequent Hospital Care With Straightforward Or Low Level of Medical Decision Making, Per Day, If Using Time, at Least 25 Minutes99231 | 234 | $46 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 200 | $81 |
| Test to Determine Lung Volumes Using Sensors94726 | 107 | $11 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 107 | $8 |
| Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060 | 106 | $9 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 103 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 11 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 197 | 54 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 99 | 47 |
| Roflumilast | 43 | — |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 25 | — |
| Montelukast Sodium | 15 | — |
| Albuterol Sulfatebrand: Ventolin Hfa | 15 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,243 across 57 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-14
- Last updated
- 2016-03-25
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.